Easy To Use Cd31 Monoclonal Antibody Stored At -20°c Holiday Cheer Edition [ITU0ND5w]

CD31 Monoclonal Antibody: Precision in Angiogenesis Research

The CD31 Monoclonal Antibody is a specialized tool designed for researchers in the field of angiogenesis and tumor biology. This high-quality antibody offers precise and reliable results, making it an essential component for various applications. With its specific reactivity to human CD31, it provides a sensitive and specific marker for endothelial cells, platelets, and other cell types involved in angiogenesis. The antibody's superior performance ensures accurate differentiation between benign and malignant angiogenic tumors, making it a crucial resource for both basic research and clinical diagnostics.

Product Specifications and Storage

This CD31 Monoclonal Antibody is derived from mice and is optimized for use in Immunohistochemistry (IHC-P). The antibody is stored at -20°C, ensuring its stability and longevity. The concentrated form of the antibody should be protected from light to maintain its integrity. Each lot is validated for a shelf life of 12 months, offering researchers a reliable and consistent supply. The antibody's cellular localization is primarily in the cell membrane and cytoplasm, and it exhibits tissue specificity in the placenta. The table below outlines the key features and specifications of the CD31 Monoclonal Antibody:

• Host: Mouse
• Reactivity: Human
• Applications: IHC-P
• Synonyms: CD31
• Cellular Localization: Cell membrane/Cytoplasm
• Tissue Specificity: Placenta
• Storage: -20°C, protect from light, valid for 12 months
• Shipping: Ice bag

Applications and Benefits

The CD31 Monoclonal Antibody is a versatile tool that finds extensive use in both research and clinical settings. Its high sensitivity and specificity make it ideal for identifying and characterizing angiogenic tumors, which is crucial for both diagnosis and treatment planning. Researchers can utilize this antibody for a variety of applications, including the assessment of tumor microenvironment, the evaluation of therapeutic response, and the study of angiogenesis in various diseases. By offering a clear and detailed view of the angiogenic process, the CD31 Monoclonal Antibody empowers scientists to make significant advancements in the understanding and treatment of diseases related to angiogenesis.